
Research compound
Tesamorelin
£46.00/ 10mg vial
Dosage
Stabilised GHRH(1-44) analogue, 44 amino acids
Tesamorelin is a synthetic analogue of human growth-hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoic acid modification at the N-terminus that protects it from dipeptidyl peptidase degradation. It is the longest peptide in our catalogue and acts at the GHRH receptor in published pharmacology.
Regent Peptides supplies tesamorelin as a lyophilised powder in two strengths, UK manufactured and released against independent HPLC and mass-spectrometry results.
It appears in research on GHRH receptor signalling, pituitary somatotroph models and visceral adipose tissue in preclinical and clinical literature. Laboratory research use only.
Order before 3pm for same-day UK dispatch on Royal Mail Tracked 24, from £4.99.
Independent testing
All lab reports- Tesamorelin 10mg90725-RTFTEPXURPDHView certificate
Third-party analysis by Janoshik Analytical. Each certificate is verifiable on the laboratory’s own site.
- Manufactured and lyophilised in the UK
- Plain, tracked packaging from £4.99
- For laboratory research use only
Research Handling Guidance
Before reconstitution, allow both the lyophilised peptide and your chosen diluent to settle at normal laboratory room temperature. Equalising temperatures in this way supports the structural stability of the compound while it goes into solution.
Diluents and reconstitution solutions are purchased separately.